Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 207 across all filing types
Latest filing 2023-03-28 Regulatory Filings
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 100% confidence The document contains only a digital signature and a date, with no substantive content or financial data. It is extremely short (114 characters) and does not include any report or announcement details. This fits the criteria for a Regulatory Filing (RNS) as it is likely an attestation or certification without report content.
2023-03-28 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document contains a letter addressed to stock exchanges regarding the publication of un-audited financial results for the quarter ended 31.12.2022. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes financial data for the quarter. The document is about quarterly financial results and includes actual financial figures, not just an announcement of a report or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 15,000 characters, indicating it is substantive and not just a brief announcement.
2023-02-16 English
Financial Result Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (1162 characters) and contains only digital signature information without any substantive content such as financial data, report titles, or regulatory references. There is no indication of a full report or detailed announcement. The content resembles an officer certification or attestation, which typically falls under Regulatory Filings (RNS) as per the certification rule. Therefore, the document is best classified as a Regulatory Filing (RNS).
2023-02-14 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document text is extremely short (274 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. This matches the characteristics of a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2023-01-31 English
Updates
Regulatory Filings Classification · 95% confidence The document consists of certificates issued under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended December 31, 2022. These certificates confirm that details of securities dematerialized/rematerialized during the quarter have been furnished to stock exchanges. The document is a regulatory compliance certificate rather than a financial report or announcement of voting results, management changes, or capital changes. It is not a full financial report or earnings release, nor is it a proxy or AGM material. The document is a formal regulatory filing to stock exchanges and regulatory bodies confirming compliance with SEBI regulations. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is about 5705 characters, which is consistent with a certificate rather than a full report.
2023-01-20 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (112 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed information. Given the lack of content, this is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2022-12-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.